Clinical Trial Update: HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) [Phase 3]

View source ↗

Summary

Clinical trial update for NTLA-2002 in hereditary angioedema (HAE). It is a Phase 3 study sponsored by Intellia Therapeutics and is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• NTLA-2002 (NTLA-2002)

Snippet

Sponsor: Intellia Therapeutics | Conditions: Hereditary Angioedema | Phase 3 | Status: ACTIVE_NOT_RECRUITING